Gerresheimer has produced the flacon for Baldessarini Signature on behalf of Mäurer & Wirtz. The heavy, high-quality glass flacon is finished in elegant deep blue and symbolizes simple, stylish and timeless elegance. Its clear, elegant design with a certain extravagance matches the expressive fragrance composition.
Biopharmaceuticals demonstrate a series of special features. They are often highly viscous and in individual cases tend to interact with silicone oil or, for example, tungsten residue from syringe production. Gerresheimer therefore offers integrated thin-walled cannulas for the improved emptying capability of the syringe for these applications. The special silicone treatment for the reduction of free silicone oil (baked-on) and the "metal-free" production without tungsten pin create a perfect primary packaging material for these sophisticated medications.
A problem when using syringes can be traces of tungsten or other metals that occasionally remain behind when shaping the syringe cone in the bore. Especially for medications based on biotechnologically manufactured active ingredients, our customers therefore require pre-fillable syringes that ideally exclude the possibility of contamination with metal. With the development of an innovative production technology registered for patent, we have been able to address this wish and create a metal-free 1 ml long Luer Lock Gx RTF syringe that is ready for series production. A transfer to other Luer Lock syringe sizes or to Luer cone syringes of various sizes is possible at all times.
The pin used to shape the cone with the new technology is no longer made from the tungsten usually used or an alternative metal, but instead of a special ceramic. External tests show that the new process for shaping the cone works free of residue. This means that not only traces of metal, but also contamination through the ceramics used are excluded. The Institut Fresenius neither found ceramic particles nor detected tissue reactions in a separate bio-compatibility study.
Baked-on siliconization for the reduction of free silicone oil
Pre-fillable syringes are very often used for the storage and administering of biotechnological medications. They are generally siliconized in order to ensure the lowest possible and most constant forces possible for the storage duration when using the syringe. The siliconization also hydrophobizes the glass surface and in this way ensures the complete emptying capability for the medication and a low level of interaction of the active ingredient with the glass. However, high silicone quantities result in the formation of the smallest silicone droplets in the solution, onto which the active ingredient can coagulate and is then no longer bioavailable.
With our Gx Baked-on RTF syringes patented in Europe and the USA, Gerresheimer has therefore developed a technology that achieves gap-free coating with the lowest quantities of silicone possible. In this process, a silicone oil emulsion is sprayed into the syringe body and subsequently affixed to the surface by heating. Despite the considerably reduced amount of silicone used and the correspondingly minimized load of free silicone droplets, the syringes provide a reliable smooth coating, as well as stable breakaway and sliding forces over the entire storage period. Gerresheimer can also equip the syringes with thin-walled cannulas that ease the administering of the often highly viscous medications thanks to their improved flow properties.
Consumers are placing great importance on sustainable products, specifically on sustainable packaging solutions that can be disposed of in an environmentally friendly way. A pioneer in the quest for greater sustainability, Gerresheimer offers an extensive standard range of plastic packaging and devises customized solutions made from PET, R-PET, and BIO-PET plastics.
Glass production begins with engineering the mould. The more accurately the moulds are designed and made, the greater the quality of the bottle. A perfect and even distribution of glass is the key to success when it comes to ensuring the robustness and sustainability of these highly sensitive products. Gerresheimer employs innovative simulation software for this purpose.
Gerresheimer is driving sustainable cosmetic glass packaging by using more post-consumer recycled glass
As a leading producer of glass packaging for cosmetic products, Gerresheimer is committed to driving sustainability in the sector. Gerresheimer has been successfully producing glass with a high proportion of post-consumer recycled (PCR) material for over 10 years in Momignies, Belgium.
"People buy scent with their eyes,” says Bernd Stauch, Senior Director Sales Cosmetics at Gerresheimer. Gerresheimer’s new high-performance Decoration Centers at Momignies in Belgium and Tettau in Germany employ the latest technology such as UV printing, to ensure that perfume products look as good as they smell.
Gerresheimer’s factories in Tettau (Germany) and Momignies (Belgium) specialize in the industrial production of cosmetic glass and have been supplying notable customers in the cosmetics industry for decades. At both sites, newly created, high-performance “Decoration Centers” use modern techniques to customize sophisticated branded products for the cosmetics market.
Gerresheimer's Gx Elite vials help ensure patient safety
With its Gx Elite and Gx RTF vials, Gerresheimer presents two new type I vials made from borosilicate glass. The Gx Elite vials are the result of a careful product development process spanning several years. The highly shatter-resistant vials are extremely durable, free of cosmetic defects and can be customized for specialized customer requirements.
Gerresheimer is investing a mid-double-digit million Euro figure in the new plant in the North Macedonian capital of Skopje, an amount that is already included in the company’s medium-term investment plans. Construction is beginning in the first half of 2019, with completion scheduled for the first half of 2020. It is expected that start of production will take place in the second half of 2020.
Gerresheimer will use this year's Pharmapack held in Paris, Porte de Versailles, as a platform to unveil their latest ophthalmology and rhinology services at booth B62. The company has teamed up with select certified partners to add surface finishing of plastic dropper bottles to their irradiation services.
The Gerresheimer Group increased revenues at constant exchange rates by 8.8% in the third quarter of 2018, from EUR 335.0m in the prior-year quarter to EUR 364.4m. This includes EUR 3.5m from Sensile Medical, which was acquired in July 2018. On an organic basis—meaning adjusted for exchange rate effects and Sensile Medical—revenues went up by 7.8% relative to the prior-year quarter.
Gerresheimer's handy Duma Pocket tablet containers are well-known for being drugs containers that fit into any bag. Because they are oval, they don't take up much space. Another great feature is that it can't open itself when it's inside a bag. It’s irritating when this happens and the tablets become loose. This is also beneficial when sending the product to users in the mail.
Gerresheimer extends business model and increases growth forecast
Gerresheimer is acquiring Swiss technology company Sensile Medical AG and thus fundamentally extends its business model. The acquisition enables Gerresheimer to offer drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.
Cosmetics packaging – Gerresheimer provides persuasive evidence through the appeal of glass
Gerresheimer belongs to the leading worldwide suppliers of glass for cosmetics. The company offers its visitors on May 10 and 11 at Luxepack 2017 in New York and at Beautyworld Middle East on May 14 up to 17 in Dubai the latest highlights out of enchanting new glass containers.
Gerresheimer presents the first US bottle produced in multilayer at CPhI 2016
Gerresheimer is presenting an extension of our new multilayer plastic container, Duma Twist-Off Protect, at CPhI. Now the popular Triveni Round family has been extended by a 60 ml container with the multilayer features for the US market.
Highest quality vials: Gerresheimer consistently implements its vial machine strategy
Gerresheimer has set up an investment program spanning several years to install state-of-the-art converting machines for vial manufacturing at all its plants. The latest-generation machines and global high standards will enable it to meet even more stringent future requirements of product quality.
Gerresheimer banks on photovoltaics in Kundli, India
Being the leading global partner for the pharmaceutical and healthcare industries, Gerresheimer is committed to sustainability and environmental protection. The majority of Triveni Polymers in Kundli (India) belongs to the Gerresheimer Group since 2012.
- Elias Bittan
- Created 12 Jan 2017
- Modified 25 May 2017
- Hits 1708